PHR3060

Nicotine Related Compound A/EP Impurity A

pharmaceutical secondary standard, certified reference material

Manufacturer: Supelco

CAS Number: 2743-90-0

Synonym(S): Anatabine, (RS)-Anatabine, (±)-Anatabine, 1,2,3,6-Tetrahydro-2,3′-bipyridine, 1,2,3,6-Tetrahydro-2,3′-dipyridine

Select a Size

Pack Size SKU Availability Price
50 MG PHR3060-50-MG In Stock ₹ 61,929.83

PHR3060 - 50 MG

₹ 61,929.83

In Stock

Quantity

1

Base Price: ₹ 61,929.83

GST (18%): ₹ 11,147.369

Total Price: ₹ 73,077.199

grade

certified reference materialpharmaceutical secondary standard

Quality Level

300

Agency

traceable to USP 1463326

API family

nicotine

CofA

current certificate can be downloaded

packaging

pkg of 50 mg

application(s)

pharmaceutical

storage temp.

2-8°C

InChI

1S/C10H12N2/c1-2-7-12-10(5-1)9-4-3-6-11-8-9/h1-4,6,8,10,12H,5,7H2

InChI key

SOPPBXUYQGUQHE-UHFFFAOYSA-N

Other Options

Related Products

Img

Supelco

PHR3061

pharmaceutical secondary standard, ...

Img

Supelco

PHR3064

pharmaceutical secondary standard, ...

Img

Supelco

PHR3063

pharmaceutical secondary standard, ...

Img

Supelco

PHR3593

certified reference material, pharm...

Description

  • General description: Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
  • Application: These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
  • Biochem/physiol Actions: Anatabine is a blood-brain barrier penetrant minor alkaloid, a cholinergic agonist, isolated from Solanaceae plant family that exhibits anti-inflammatory properties. Apparently, anti-inflammatory properties of anatabine are partially mediated by inhibition of STAT3 and p65 NFkB phosphorylation. Anatabine decreases the transcription and protein synthesis of β-secretase (BACE-1), and appears to ameliorate experimental autoimmune thyroiditis and encephalomyelitis.
  • Analysis Note: These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
  • Other Notes: This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

SAFETY INFORMATION

Pictograms

GHS06

Signal Word

Danger

Hazard Statements

H301,H319

Precautionary Statements

P264 - P270 - P280 - P301 + P310 - P305 + P351 + P338 - P337 + P313

Hazard Classifications

Acute Tox. 3 Oral - Eye Irrit. 2

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable